Insider Transactions in Q4 2022 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2022
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
678
-4.01%
|
$170,178
$251.72 P/Share
|
|
Dec 16
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
25,211
-7.44%
|
$6,151,484
$244.63 P/Share
|
|
Dec 05
2022
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,333
-46.57%
|
$2,438,588
$236.76 P/Share
|
|
Dec 02
2022
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,333
+49.32%
|
$0
$0.94 P/Share
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Direct |
24,115
+17.52%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Indirect |
12,231
+9.25%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
36,346
-100.0%
|
-
|
|
Nov 18
2022
|
Philip Ebeling Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
167
-40.73%
|
-
|
|
Nov 11
2022
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
9,217
-57.05%
|
$2,036,957
$221.58 P/Share
|
|
Nov 11
2022
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,277
+37.5%
|
$0
$0.94 P/Share
|
|
Nov 08
2022
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
2,000
-8.83%
|
-
|
|
Oct 17
2022
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+14.99%
|
$0
$0.94 P/Share
|
|
Oct 11
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Indirect |
35,117
+49.14%
|
-
|
|
Oct 11
2022
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Direct |
35,117
-28.19%
|
-
|
|
Oct 11
2022
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
129
+3.09%
|
$21,672
$168.98 P/Share
|
|
Oct 11
2022
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+20.0%
|
$13,608
$168.98 P/Share
|
|
Oct 11
2022
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51
+50.0%
|
$8,568
$168.98 P/Share
|
|
Oct 11
2022
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
81
+0.41%
|
$13,608
$168.98 P/Share
|
|
Oct 11
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Exercise of conversion of derivative security
|
Direct |
68,787
+13.12%
|
$1,169,379
$17.82 P/Share
|
|
Oct 11
2022
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
88
+3.85%
|
$14,784
$168.98 P/Share
|
|
Oct 11
2022
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+14.91%
|
$14,280
$168.98 P/Share
|